author = { Mellinghoff, Ingo K. AND Sawyers, Charles L. AND Mellinghoff, Ingo Kai },

title = { Therapeutic kinase inhibitors },

publisher = {Springer},

isbn = {9783642282959},

isbn = {3642282954},

keywords = { Cancer Chemotherapy , Antineoplastic agents , Neoplasms drug therapy , Protein Kinase Inhibitors therapeutic use , Antineoplastic Agents therapeutic use , Drug Discovery , Adenosine Triphosphate therapeutic use , Aufsatzsammlung , Krebs Medizin , Proteinkinasen , Enzyminhibitor },

year = {2012},

abstract = {Literaturangaben},

abstract = {Setting up a kinase discovery and development project Gideon Bollag},

abstract = {Drug efficacy testing in mice William Y. Kim and Norman E. Sharpless},

abstract = {Gastrointestinal stromal tumors Cristina Antonescu},

abstract = {EGFR mutant lung cancer Yixuan Gong and William Pao},

abstract = {Targeting oncogenic BRAF in human cancer Christine A. Pratilas, Feng Xing and David B. Solit},

abstract = {Beyond BRAF in melanoma Adil Daud and Boris C. Bastain},

abstract = {JAK-mutant myeloproliferative neoplasms Ross L. Levine},

abstract = {Will kinase inhibitors make it as glioblastoma drugs? Ingo K. Mellinghoff ... [et al.]},

abstract = {Predictive genomic biomarkers Rakesh Kumar and Rafael G. Amado},

abstract = {Epigentic biomarkers Timothy A. Chan and Stephen B. Baylin},

abstract = {Adjuvant trials of targeted agents : the newest battleground in the war on cancer Robert L. Cohen.},

booktitle = {Current topics in microbiology and immunology ; 355},

address = { Berlin },

url = { http://slubdd.de/katalog?TN_libero_mab2 }